ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1082

Reducing No-shows and Late Cancellations at an Academic Medical Center Subspecialty Clinic

Nicola Jackson1, Meg James2, Kim Nguyen3, Priyanka Vashisht2 and Avis Ware4, 1University of Cincinnati, Rheumatology, Blue Ash, OH, 2University of Cincinnati Medical Center, Cincinnati, OH, 3University of Cincinnati Medical Center, Loveland, OH, 4University of Cincinnati College of Medicine, Loveland, OH

Meeting: ACR Convergence 2023

Keywords: Access to care, Health Care, quality of care, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1082–1099) Measures & Measurement of Healthcare Quality Poster I

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient no-shows and late cancellations, defined as less than 24 hours from the visit, reduce operational efficiency, revenue generation, and lead to negative clinical outcomes. There has been an increasing trend in no-show and late cancellation rates at the University of Cincinnati Hoxworth rheumatology clinic. For fiscal year 2021, monthly rates ranged from 6.2-32.7%. Since each unused slot is not reimbursable, this has resulted in a negative financial impact. When extrapolated to all of Internal Medicine, this has led to a $2 million revenue loss. Previously, reminders for visits involved automated calls and mailing letters. Using Vizient clinical database to identify performance gaps, our smart aim was to integrate phone call reminders to decrease median benchmark for no-shows and late cancellation rates from 18.47% to 14.6% from October 31, 2022 to February 1, 2023.

Methods: The 1st Plan-Do-Study-Act (PDSA) involved identifying the optimal lead time to call and was from October 31, 2022 to December 31, 2022. The 2nd aimed to refine phone call and messaging scripts and was from January 1 to February 1, 2023. Patients were called from 1 to 6 days prior to the visit. Alternate numbers or patient portals were used if they could not be reached. Conversations and barriers were documented in the medical record. To assess for common and special cause variations, baseline rates were plotted on a run chart starting from November 22, 2021 to April 14, 2023 (Figure 1).

Results: Monthly attendance ranged from 64.3-96.3% from October 31, 2022 to February 1, 2023 (N=11-30 patients per visit). The lowest rates were during Thanksgiving at 72.7% (N=22) and Christmas at 64.3% (N=14). Data for Thanksgiving and Christmas for 2021 were similarly low with median attendance of 74.55% (N=33-66). When excluding these holidays, the median rate was above the set benchmark of 85%. We concluded that low rates during holidays are special cause variations and can show positive shift if project is of a longer duration. After the project ended on February 1, 2023, rates dropped again below the benchmark to median of 80.6%. During PDSA #1 the optimal time to call was 5 to 6 days prior allowing for identification of barriers, some of which included transportation or work obligations. If barriers could not be resolved, patients on wait lists filled the open slots. During PDSA #2, late cancellations became increasingly higher than no-shows since they were unaware of the policy. There was a positive trend in attendance once scripts were refined to explicitly inform all patients of the policy. Also, phone calls were more effective than mailed letters or patient portal messaging due to the lead time and ability to identify barriers.

Conclusion: Monthly attendance ranged from 64.3-96.3% from October 31, 2022 to February 1, 2023. When excluding no-shows and late cancellations during Thanksgiving and Christmas, the median attendance rate was above the set benchmark of 85%. Low rates during holidays are special cause variations and can show positive shift if the next phase of the project is longer. The optimal time to call is 5 to 6 days prior and are opportunities to identify barriers and to fill open slots. There was a positive trend once scripts included explanation of the policy.

Supporting image 1

Figure 1. Monthly Attendance Rates Run Chart


Disclosures: N. Jackson: None; M. James: None; K. Nguyen: None; P. Vashisht: None; A. Ware: None.

To cite this abstract in AMA style:

Jackson N, James M, Nguyen K, Vashisht P, Ware A. Reducing No-shows and Late Cancellations at an Academic Medical Center Subspecialty Clinic [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/reducing-no-shows-and-late-cancellations-at-an-academic-medical-center-subspecialty-clinic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reducing-no-shows-and-late-cancellations-at-an-academic-medical-center-subspecialty-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology